Endpoints honors 20 women leaders; Vertex teams up with neighbor; Pfizer rival impresses; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
Our website will be buzzing this weekend with live #ASH22 coverage from Kyle LaHucik and Paul Schloesser, so be sure to check the website from time to time. They are also hosting a panel of experts to discuss key takeaways from the conference on Monday — you can sign up at no cost here. Another housekeeping note: I’m taking next week off, but you are in good hands with my colleague Lei Lei Wu taking over for the Endpoints Weekly.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 157,800+ biopharma pros reading Endpoints daily — and it's free.